Cost-Effectiveness of an Injury and Drowning Prevention Program in Bangladesh

被引:106
作者
Rahman, Fazlur [1 ]
Bose, Saideep
Linnan, Michael [3 ]
Rahman, Aminur [2 ]
Mashreky, Saidur [1 ]
Haaland, Benjamin
Finkelstein, Eric [4 ]
机构
[1] New DOHS Mohakhali, Ctr Injury Prevent & Res, Dhaka, Bangladesh
[2] New DOHS Mohakhali, Int Drowning Res Ctr Bangladesh, Dhaka, Bangladesh
[3] Alliance Safe Children, Bangkok, Thailand
[4] Duke NUS Grad Med Sch, Hlth Serv & Syst Res Program, Singapore 169857, Singapore
关键词
drowning; injury; mortality; cost-effectiveness; LMIC; CHILDHOOD; ASSOCIATION; MORTALITY; HEALTH;
D O I
10.1542/peds.2012-0757
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: Interventions that mitigate drowning risk in developing countries are needed. This study presents the cost-effectiveness of a low-cost, scalable injury and drowning prevention program called Prevention of Child Injuries through Social-Intervention and Education (PRECISE) in Bangladesh. METHODS: Between 2006 and 2010, the 2 components of PRECISE (Anchal, which sequestered children in creches [n = 18 596 participants], and SwimSafe, which taught children how to swim [n = 79421 participants]) were implemented in rural Bangladesh. Mortality rates for participants were compared against a matched sample of non-participants in a retrospective cohort analysis. Effectiveness was calculated via Cox proportional hazard analysis. Cost-effectiveness was estimated according to World Health Organization-CHOosing Interventions that are Cost Effective guidelines. RESULTS: Anchal costs between $50.74 and $60.50 per child per year. SwimSafe costs $13.46 per child. For Anchal participants, the relative risk of a drowning death was 0.181 (P = .004). The relative risk of all-cause mortality was 0.56 (P = .001). For SwimSafe, the relative risk of a drowning death was 0.072 (P < .0001). The relative risk of all-cause mortality was 0.750 (P = .024). For Anchal, the cost per disability-adjusted life-year (DALY) averted is $812 (95% confidence interval: $589-$1777). For SwimSafe, the cost per DALY averted is $85 ($51-$561). Combined, the cost per DALY averted is $362 ($232-$1364). CONCLUSIONS: Based on World Health Organization criteria, PRECISE is very cost-effective and should be considered for implementation in other areas where drowning is a significant problem. Pediatrics 2012;130:e1621-e1628
引用
收藏
页码:E1621 / E1628
页数:8
相关论文
共 50 条
  • [41] Cost-effectiveness of prevention of venous thromboembolism
    Sharp, B.
    Davies, A. H.
    PHLEBOLOGY, 2006, 21 : 29 - 31
  • [42] Cost-effectiveness of the Norwegian breast cancer screening program
    van Luijt, P. A.
    Heijnsdijk, E. A. M.
    de Koning, H. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 833 - 840
  • [43] The cost-effectiveness of the Olweus Bullying Prevention Program: Results from a modelling study
    Beckman, Linda
    Svensson, Mikael
    JOURNAL OF ADOLESCENCE, 2015, 45 : 127 - 137
  • [44] QALYs and cost-effectiveness thresholds: critical reflections
    Rogalewicz, Vladimir
    Bartak, Miroslav
    CENTRAL EUROPEAN CONFERENCE IN FINANCE AND ECONOMICS (CEFE2017), 2017, : 664 - 677
  • [45] Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting
    Wu, Bin
    Wan, Xu
    Ma, Jing
    JOURNAL OF DIABETES, 2018, 10 (04) : 320 - 327
  • [46] Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation
    Kebede, Tayue Tateke
    Svensson, Mikael
    Addissie, Adamu
    Trollfors, Birger
    Andersson, Rune
    BMC PUBLIC HEALTH, 2019, 19 (01)
  • [47] Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension
    Zhang, Tiantian
    Liang, Zhuoru
    Lin, Tengfei
    Cohen, David J.
    Arrieta, Alejandro
    Wang, Xiaobin
    Qin, Xianhui
    Wang, Binyan
    Huo, Yong
    Liu, Gordon G.
    Jiang, Jie
    Zhang, Zugui
    BMC MEDICINE, 2022, 20 (01)
  • [48] Value of hospital resources for effective pressure injury prevention: a cost-effectiveness analysis
    Padula, William V.
    Pronovost, Peter J.
    Makic, Mary Beth F.
    Wald, Heidi L.
    Moran, Dane
    Mishra, Manish K.
    Meltzer, David O.
    BMJ QUALITY & SAFETY, 2019, 28 (02) : 132 - 141
  • [49] Cost-Effectiveness of Cervical Cancer Prevention in Central and Eastern Europe and Central Asia
    Berkhof, Johannes
    Bogaards, Johannes A.
    Demirel, Erhan
    Diaz, Mireia
    Sharma, Monisha
    Kim, Jane J.
    VACCINE, 2013, 31 : H71 - H79
  • [50] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Lip, Gregory Y. H.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Chalkiadaki, Corina
    Liu, Xianchen
    Kuznik, Andreas
    Lawrence, Jack
    Dorian, Paul
    CLINICAL THERAPEUTICS, 2015, 37 (11) : 2476 - 2488